Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

US stocks: Capricor shares 77% soar as potential FDA lifeline revives Duchenne drug hopes

Capricor Therapeutics shares surged 77% ​on Friday after the company said the U.S. health regulator ​is willing to review new data on its experimental Duchenne muscular dystrophy drug.

The stock had crashed last month after an FDA advisory panel voted nine-to-three against the effectiveness data of ‌the drug, deramiocel.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.